Skip to content
10-Q/A

Quarterly Report

CURATIVE BIOSCIENCES, INC.

0001493152-18-000552

← back to feed
Filed
Jan 16, 2018 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Jul 28, 2017 15.71M sh
Operating Cash Flow Q3 2017 · Mar 31, 2017 −$11.12K
Operating Cash Flow Q3 2017 · Mar 31, 2016 −$22.51K
Stockholders Equity Q3 2017 · Mar 31, 2017 −$612.91K
Stockholders Equity Q3 2017 · Jun 30, 2016 −$615.11K
Current Liabilities Q3 2017 · Mar 31, 2017 $615.88K
Current Liabilities Q3 2017 · Jun 30, 2016 $620.22K
Total Liabilities Q3 2017 · Mar 31, 2017 $615.88K
Total Liabilities Q3 2017 · Jun 30, 2016 $620.22K
Total Assets Q3 2017 · Mar 31, 2017 $2.98K
Total Assets Q3 2017 · Jun 30, 2016 $5.11K
Net Income restated Q3 2017 · Mar 31, 2017 $4K
Net Income Q3 2017 · Mar 31, 2017 −$35.3K
Net Income restated Q3 2017 · Mar 31, 2016 $5.32K
Net Income Q3 2017 · Mar 31, 2016 −$1.61M
Operating Income restated Q3 2017 · Mar 31, 2017 $4K
Operating Income Q3 2017 · Mar 31, 2017 −$35.3K
Operating Income restated Q3 2017 · Mar 31, 2016 $5.32K
Operating Income Q3 2017 · Mar 31, 2016 −$1.61M
Cash And Equivalents Q3 2017 · Jun 30, 2015 $2K